The clinicopathological features of programmed death ligand-1 expression in colorectal carcinoma.

Al-Jussani, Ghada N; Alsughayer, Anas; Yousuf, Mustafa S; Mullahuwash, Yaseen; Dabbagh, Tamara; Sughayer, Maher A

Al-Jussani, Ghada N; Alsughayer, Anas; Yousuf, Mustafa S; Mullahuwash, Yaseen; Dabbagh, Tamara; Sughayer, Maher A.

Afiliación

Al-Jussani GN; Department of Basic Medical Sciences, 108598Faculty of Medicine, The Hashemite University, Zarqa, Jordan.
Alsughayer A; 37559King Hussein Cancer Center, Amman, Jordan.
Yousuf MS; Department of Basic Medical Sciences, 108598Faculty of Medicine, The Hashemite University, Zarqa, Jordan.
Mullahuwash Y; Faculty of Medicine, 54658University of Jordan, Amman, Jordan.
Dabbagh T; 37559King Hussein Cancer Center, Amman, Jordan.
Sughayer MA; 37559King Hussein Cancer Center, Amman, Jordan.

Int J Biol Markers ; 37(3): 322-327, 2022 Sep.

Article en En | MEDLINE | ID: mdl-35635229

Asunto(s)

Antígeno B7-H1; Neoplasias Colorrectales; Antígeno B7-H1/genética; Antígeno B7-H1/metabolismo; Biomarcadores de Tumor/genética; Biomarcadores de Tumor/metabolismo; Neoplasias Colorrectales/metabolismo; Humanos; Pronóstico

Palabras clave

Colorectal cancer; PD-L1; biomarkers; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antígeno B7-H1 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Int J Biol Markers Asunto de la revista: BIOQUIMICA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Jordania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google